Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltration.

Fratoni, Andrew J; Kuti, Joseph L; Nicolau, David P

Fratoni, Andrew J; Kuti, Joseph L; Nicolau, David P.

Affiliation

Fratoni AJ; Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.
Kuti JL; Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.
Nicolau DP; Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA. Electronic address: david.nicolau@hhchealth.org.

Int J Antimicrob Agents ; 58(3): 106395, 2021 Sep.

Article in En | MEDLINE | ID: mdl-34192592

Subject(s)

Cephalosporins/pharmacology; Cephalosporins/therapeutic use; Coinfection/drug therapy; Gram-Negative Bacterial Infections/drug therapy; Pneumonia/drug therapy; Stenotrophomonas maltophilia/drug effects; Stenotrophomonas maltophilia/immunology; Anti-Bacterial Agents/pharmacology; Anti-Bacterial Agents/therapeutic use; Continuous Renal Replacement Therapy; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Male; Middle Aged; Cefiderocol

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pneumonia / Cephalosporins / Gram-Negative Bacterial Infections / Stenotrophomonas maltophilia / Coinfection Limits: Humans / Male / Middle aged Language: En Journal: Int J Antimicrob Agents Year: 2021 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google